Obicetrapib potassium
Obicetrapib (TA-8995; DEZ-001) potassium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib potassium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib potassium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 866399-90-8
- 分子式: C32H30F9KN4O5
- 分子量:760.69
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
化学情報
-
CAS 番号 866399-90-8
-
分子量 760.69
-
分子式 C32H30F9KN4O5
-
SMILES
FC(F)(F)C1=CC(C(F)(F)F)=CC(CN(C2=NC=C(OCCCC(O[K])=O)C=N2)[C@@H]3C4=CC(C(F)(F)F)=CC=C4N([C@@H](C3)CC)C(OCC)=O)=C1
-
別名
TA-8995 potassium; DEZ-001 potassium; AMG-899 potassium
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- Obicetrapib
- 866399-90-8
- TA-8995
- DEZ-001
- AMG-899
- TA8995
- TA 8995
- DEZ001
- DEZ 001
- AMG899
- AMG 899
- Apolipoprotein
- LDLR
- LPL Receptor
- CETP
- dyslipidaemia
- apolipoprotein B
- high-intensity statins
- apoB
- LDL-C
- high-density lipoprotein cholesterol
- cholesteryl ester transfer protein
- low-density lipoprotein cholesterol
- HDL-C
- Inhibitor
- inhibitor
- inhibit